source
- AstraZeneca and CSPC launch joint venture to build biologics plant in ShijiazhuangAstraZeneca and China's CSPC Pharmaceutical have formed a joint venture to construct a biologics manufacturing facility in Shijiazhuang. The agreement follows AstraZeneca's pledge earlier this year…
- Sanofi faces shortage of two Pompe disease drugs after FDA flags manufacturing issuesSanofi has reported a shortage of two medicines used to treat Pompe disease. The shortage emerged after the U.S. Food and Drug Administration issued a warning about manufacturing problems at the co…